Clinical Trial Update: The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMI [Phase 4]

View source ↗

Summary

Clinical trial evaluating the efficacy and safety of ketotifen in patients undergoing primary PCI for STEMI (Phase 4). The study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Ketotifen (Ketotifen)

Snippet

Sponsor: Peking University Third Hospital | Conditions: ST-segment Elevation Myocardial Infarction (STEMI) | Phase 4 | Status: UNKNOWN